Genecker

Total Funding
$6.3M
Last Round
$6.3M Series AMay 2022
Rounds
1

About

NGS-based cancer diagnostic kits and reagents

Summary

It has raised $6.3M in total across 1 round, most recently a $6.3M Series A round in May 2022. Investors include Premier Inc., UTC Investment and Magna Capital Partners.

Sign up to view the funding chart

Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.

Funding History

Series ASeries AMay 2022
$6.3M

Investors